J
Jerrold J. Heindel
Researcher at National Institutes of Health
Publications - 118
Citations - 16262
Jerrold J. Heindel is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Environmental exposure & Disease. The author has an hindex of 52, co-authored 112 publications receiving 14060 citations. Previous affiliations of Jerrold J. Heindel include United States Department of Health and Human Services & Research Triangle Park.
Papers
More filters
Journal ArticleDOI
Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses
Laura N. Vandenberg,Theo Colborn,Tyrone B. Hayes,Jerrold J. Heindel,David R. Jacobs,Duk Hee Lee,Toshi Shioda,Ana M. Soto,Wade V. Welshons,R. Thomas Zoeller,John Peterson Myers +10 more
TL;DR: It is concluded that when nonmonotonic dose-response curves occur, the effects of low doses cannot be predicted by the effects observed at high doses, and fundamental changes in chemical testing and safety determination are needed to protect human health.
Journal ArticleDOI
State of the Science of Endocrine Disrupting Chemicals - 2012
TL;DR: The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of UNEP or WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
Journal ArticleDOI
Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A.
Laura N. Vandenberg,Ibrahim Chahoud,Jerrold J. Heindel,Vasantha Padmanabhan,Francisco José Roma Paumgartten,Gilbert Schoenfelder +5 more
TL;DR: Available data from biomonitoring studies clearly indicate that the general population is exposed to BPA and is at risk from internal exposure to unconjugated BPA.
Journal ArticleDOI
Endocrine disrupting chemicals and disease susceptibility.
TL;DR: This review focuses on the mechanisms and modes of action by which EDCs alter hormone signaling, and includes brief overviews of select disease endpoints associated with endocrine disruption.
Journal ArticleDOI
Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure.
Frederick S. vom Saal,Benson T. Akingbemi,Scott M. Belcher,Linda S. Birnbaum,D. Andrew Crain,Marcus Eriksen,Francesca Farabollini,Louis J. Guillette,Russ Hauser,Jerrold J. Heindel,Shuk-Mei Ho,Patricia A. Hunt,Taisen Iguchi,Susan Jobling,Jun Kanno,Ruth A. Keri,Karen E. Knudsen,Hans Laufer,Gerald A. LeBlanc,Michele Marcus,John A. McLachlan,John Peterson Myers,Angel Nadal,Retha R. Newbold,Nicolás Olea,Gail S. Prins,Catherine A. Richter,Beverly S. Rubin,Carlos Sonnenschein,Ana M. Soto,Chris E. Talsness,John G. Vandenbergh,Laura N. Vandenberg,Debby Walser-Kuntz,Cheryl S. Watson,Wade V. Welshons,Yelena B. Wetherill,R. Thomas Zoeller +37 more
TL;DR: This document is a summary statement of the outcome from he meeting: “Bisphenol A: An Examination of the Relevance of cological, In vitro and Laboratory Animal Studies for Assessng Risks to Human Health” sponsored by both the NIEHS and IDCR at NIH/DHHS.